Connection

Denis Guttridge to Muscle, Skeletal

This is a "connection" page, showing publications Denis Guttridge has written about Muscle, Skeletal.
Connection Strength

8.566
  1. MyoD Regulates Skeletal Muscle Oxidative Metabolism Cooperatively with Alternative NF-?B. Cell Rep. 2016 10 04; 17(2):514-526.
    View in: PubMed
    Score: 0.433
  2. Analysis of Aerobic Respiration in Intact Skeletal Muscle Tissue by Microplate-Based Respirometry. Methods Mol Biol. 2016; 1460:337-43.
    View in: PubMed
    Score: 0.411
  3. Inflammation induced loss of skeletal muscle. Bone. 2015 Nov; 80:131-142.
    View in: PubMed
    Score: 0.406
  4. A TGF-? pathway associated with cancer cachexia. Nat Med. 2015 Nov; 21(11):1248-9.
    View in: PubMed
    Score: 0.406
  5. Impaired regeneration: A role for the muscle microenvironment in cancer cachexia. Semin Cell Dev Biol. 2016 06; 54:82-91.
    View in: PubMed
    Score: 0.403
  6. NF-?B-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia. J Clin Invest. 2013 Nov; 123(11):4821-35.
    View in: PubMed
    Score: 0.354
  7. Mechanisms of impaired differentiation in rhabdomyosarcoma. FEBS J. 2013 Sep; 280(17):4323-34.
    View in: PubMed
    Score: 0.348
  8. Reining in nuclear factor-kappaB in skeletal muscle disorders. Curr Opin Clin Nutr Metab Care. 2013 May; 16(3):251-7.
    View in: PubMed
    Score: 0.342
  9. Mechanisms for maintaining muscle. Curr Opin Support Palliat Care. 2012 Dec; 6(4):451-6.
    View in: PubMed
    Score: 0.332
  10. IKKa and alternative NF-?B regulate PGC-1? to promote oxidative muscle metabolism. J Cell Biol. 2012 Feb 20; 196(4):497-511.
    View in: PubMed
    Score: 0.315
  11. Detection of NF-?B activity in skeletal muscle cells by electrophoretic mobility shift analysis. Methods Mol Biol. 2012; 798:505-16.
    View in: PubMed
    Score: 0.312
  12. Making muscles grow by g protein-coupled receptor signaling. Sci Signal. 2011 Nov 29; 4(201):pe45.
    View in: PubMed
    Score: 0.310
  13. NF-?B signaling in skeletal muscle health and disease. Curr Top Dev Biol. 2011; 96:85-119.
    View in: PubMed
    Score: 0.291
  14. TNF inhibits Notch-1 in skeletal muscle cells by Ezh2 and DNA methylation mediated repression: implications in duchenne muscular dystrophy. PLoS One. 2010 Aug 30; 5(8):e12479.
    View in: PubMed
    Score: 0.284
  15. NF-kappaB signaling: a tale of two pathways in skeletal myogenesis. Physiol Rev. 2010 Apr; 90(2):495-511.
    View in: PubMed
    Score: 0.276
  16. NF-kappaB functions in stromal fibroblasts to regulate early postnatal muscle development. J Biol Chem. 2010 Feb 19; 285(8):5479-87.
    View in: PubMed
    Score: 0.270
  17. The RelA/p65 subunit of NF-kappaB specifically regulates cyclin D1 protein stability: implications for cell cycle withdrawal and skeletal myogenesis. J Cell Biochem. 2009 Jan 01; 106(1):42-51.
    View in: PubMed
    Score: 0.253
  18. IKK/NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. J Cell Biol. 2008 Feb 25; 180(4):787-802.
    View in: PubMed
    Score: 0.239
  19. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest. 2004 Aug; 114(3):370-8.
    View in: PubMed
    Score: 0.186
  20. Signaling pathways weigh in on decisions to make or break skeletal muscle. Curr Opin Clin Nutr Metab Care. 2004 Jul; 7(4):443-50.
    View in: PubMed
    Score: 0.185
  21. Cancer cachexia: involvement of an expanding macroenvironment. Cancer Cell. 2023 03 13; 41(3):581-584.
    View in: PubMed
    Score: 0.169
  22. Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induced loss of skeletal muscle gene products. J Biol Chem. 2003 Jan 24; 278(4):2294-303.
    View in: PubMed
    Score: 0.165
  23. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science. 2000 Sep 29; 289(5488):2363-6.
    View in: PubMed
    Score: 0.143
  24. Modeling Human Cancer-induced Cachexia. Cell Rep. 2019 08 06; 28(6):1612-1622.e4.
    View in: PubMed
    Score: 0.132
  25. Dysregulated Myogenesis in Rhabdomyosarcoma. Curr Top Dev Biol. 2018; 126:285-297.
    View in: PubMed
    Score: 0.117
  26. Thrombin causes a marked delay in skeletal myogenesis that correlates with the delayed expression of myogenin and p21CIP1/WAF1. J Biol Chem. 1997 Sep 26; 272(39):24117-20.
    View in: PubMed
    Score: 0.116
  27. Mechano-signalling pathways in an experimental intensive critical illness myopathy model. J Physiol. 2016 08 01; 594(15):4371-88.
    View in: PubMed
    Score: 0.105
  28. An NF-?B--EphrinA5-Dependent Communication between NG2(+) Interstitial Cells and Myoblasts Promotes Muscle Growth in Neonates. Dev Cell. 2016 Jan 25; 36(2):215-24.
    View in: PubMed
    Score: 0.103
  29. Inflammation based regulation of cancer cachexia. Biomed Res Int. 2014; 2014:168407.
    View in: PubMed
    Score: 0.092
  30. Metabolomic profiling reveals severe skeletal muscle group-specific perturbations of metabolism in aged FBN rats. Biogerontology. 2014 Jun; 15(3):217-32.
    View in: PubMed
    Score: 0.091
  31. Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7. Proc Natl Acad Sci U S A. 2014 Mar 25; 111(12):4525-9.
    View in: PubMed
    Score: 0.091
  32. Regulation of skeletal muscle oxidative phenotype by classical NF-?B signalling. Biochim Biophys Acta. 2013 Aug; 1832(8):1313-25.
    View in: PubMed
    Score: 0.085
  33. Report on the Myomatrix Conference April 22-24, 2012, University of Nevada, Reno, Nevada, USA. Neuromuscul Disord. 2013 Feb; 23(2):188-91.
    View in: PubMed
    Score: 0.081
  34. STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia. PLoS One. 2011; 6(7):e22538.
    View in: PubMed
    Score: 0.075
  35. Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo. Nutr Cancer. 2011; 63(5):749-62.
    View in: PubMed
    Score: 0.075
  36. Systemic delivery of NEMO binding domain/IKK? inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology. Neurobiol Dis. 2011 Sep; 43(3):598-608.
    View in: PubMed
    Score: 0.075
  37. DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann Neurol. 2011 Mar; 69(3):540-52.
    View in: PubMed
    Score: 0.072
  38. Inhibition of the IKK/NF-?B pathway by AAV gene transfer improves muscle regeneration in older mdx mice. Gene Ther. 2010 Dec; 17(12):1476-83.
    View in: PubMed
    Score: 0.071
  39. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest. 2007 Apr; 117(4):889-901.
    View in: PubMed
    Score: 0.056
  40. The molecular mechanisms of skeletal muscle wasting: implications for therapy. Surgeon. 2006 Oct; 4(5):273-83.
    View in: PubMed
    Score: 0.054
  41. Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell. 2005 Nov; 8(5):421-32.
    View in: PubMed
    Score: 0.051
  42. Extracellular vesicles derived from tumour cells as a trigger of energy crisis in the skeletal muscle. J Cachexia Sarcopenia Muscle. 2022 02; 13(1):481-494.
    View in: PubMed
    Score: 0.039
  43. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol. 1999 Aug; 19(8):5785-99.
    View in: PubMed
    Score: 0.033
  44. Dual Inhibition of MEK and PI3K/Akt Rescues Cancer Cachexia through both Tumor-Extrinsic and -Intrinsic Activities. Mol Cancer Ther. 2017 02; 16(2):344-356.
    View in: PubMed
    Score: 0.027
  45. Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia. J Natl Cancer Inst. 2015 Dec; 107(12):djv274.
    View in: PubMed
    Score: 0.025
  46. Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis. Mol Ther. 2012 Jun; 20(6):1222-33.
    View in: PubMed
    Score: 0.020
  47. NF-?B negatively impacts the myogenic potential of muscle-derived stem cells. Mol Ther. 2012 Mar; 20(3):661-8.
    View in: PubMed
    Score: 0.019
  48. Immunocompetent murine model of cancer cachexia for head and neck squamous cell carcinoma. Head Neck. 2008 Mar; 30(3):320-6.
    View in: PubMed
    Score: 0.015
  49. Cancer cachexia syndrome in head and neck cancer patients: Part II. Pathophysiology. Head Neck. 2007 May; 29(5):497-507.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.